Author:
Xu He-Ping,Zhan Feng,Wang Hong,Lin Jie,Niu Huan
Funder
Natural Science Foundation of Hainan Province
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Christenson, S. A., Smith, B. M., Bafadhel, M., & Putcha, N. (2022). Chronic obstructive pulmonary disease. Lancet, 399(10342), 2227–2242.
2. Kahnert, K., Jörres, R. A., Behr, J., & Welte, T. (2023). The diagnosis and treatment of COPD and Its comorbidities. Deutsches Arzteblatt International, 120(25), 434–444.
3. Viegi, G., Pistelli, F., Sherrill, D. L., Maio, S., Baldacci, S., & Carrozzi, L. (2007). Definition, epidemiology and natural history of COPD. The European Respiratory Journal, 30(5), 993–1013.
4. Kaur, M., Chandel, J., Malik, J., & Naura, A. S. (2022). Particulate matter in COPD pathogenesis: an overview. Inflammation Research, 71(7-8), 797–815.
5. Duffy, S. P., & Criner, G. J. (2019). Chronic obstructive pulmonary disease: evaluation and management. The Medical Clinics of North America, 103(3), 453–461.